Direct Medical Costs and the Likelihood of Health Service Utilization Before and After Initiation of Avonex (Interferon β1a IM) Treatment Among Persons with Multiple Sclerosis (MS) Mar 1, 2020
Incremental Sick Leave Costs and Lost Time Among Employees with Psychiatric and Medical Conditions Mar 1, 2020
Medication adherence with Disease modifying treatments for multiple sclerosis: Findings from a US National database of employees Mar 1, 2020